Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...
Doctors are calling a first-of-its kind wireless pacemaker a game changer, saying the newly-approved device will help keep heart patients alive. Barry Lawrence, a 77-year-old Orange County resident, ...
The pacemaker device was designed for those with slow or abnormal heart rhythms, and traditionally was implanted into the heart with leads, or wires. But new advancements mean that patients can say ...
Abbott (NYSE:ABT) said it has received FDA approval for its dual-chamber leadless pacemaker system Aveir DR for the treatment of slow or abnormal heart rhythms. The medical device maker said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results